Bacillary dysentery: mechanisms and treatment.
D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D004338:Drug Combinations / Q000627:therapeutic use; D004405:Dysentery, Bacillary / Q000209:etiology* / Q000628:therapy*; D005440:Fluid Therapy; D006790:Host-Parasite Interactions; D006801:Humans; D007422:Intestines / Q000382:microbiology; D007792:Lactulose / Q000627:therapeutic use; D009268:Nalidixic Acid / Q000627:therapeutic use; D019081:O Antigens; D010093:Oxolinic Acid / Q000627:therapeutic use; D011135:Polysaccharides, Bacterial; D022603:Shiga Toxins; D012760:Shigella / Q000472:pathogenicity; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000892:Anti-Infective Agents, Urinary; D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D004338:Drug Combinations; D019081:O Antigens; D011135:Polysaccharides, Bacterial; D022603:Shiga Toxins; D009268:Nalidixic Acid; D007792:Lactulose; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D010093:Oxolinic Acid